Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05905848Phase 3Unknown
Phase 3, randomised, open-label trial in hypertension (HTN), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of persistent post-surgery hypotension at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05905848.